Cargando…
LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296919/ http://dx.doi.org/10.1016/j.jid.2022.05.941 |
| _version_ | 1784750367711428608 |
|---|---|
| author | Nosrati, A. Torpey, M.E. Ball, G.D. Shokrian, N. Campton, K.L. Cohen, S.R. |
| author_facet | Nosrati, A. Torpey, M.E. Ball, G.D. Shokrian, N. Campton, K.L. Cohen, S.R. |
| author_sort | Nosrati, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9296919 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92969192022-07-20 LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors Nosrati, A. Torpey, M.E. Ball, G.D. Shokrian, N. Campton, K.L. Cohen, S.R. J Invest Dermatol Article Published by Elsevier Inc. 2022-08 2022-07-20 /pmc/articles/PMC9296919/ http://dx.doi.org/10.1016/j.jid.2022.05.941 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Nosrati, A. Torpey, M.E. Ball, G.D. Shokrian, N. Campton, K.L. Cohen, S.R. LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title | LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title_full | LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title_fullStr | LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title_full_unstemmed | LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title_short | LB923 COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors |
| title_sort | lb923 covid-19 vaccine immunity in hidradenitis suppurativa patients receiving tnf-alpha inhibitors |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296919/ http://dx.doi.org/10.1016/j.jid.2022.05.941 |
| work_keys_str_mv | AT nosratia lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors AT torpeyme lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors AT ballgd lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors AT shokriann lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors AT camptonkl lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors AT cohensr lb923covid19vaccineimmunityinhidradenitissuppurativapatientsreceivingtnfalphainhibitors |